Azurity Pharmaceuticals' Katerzia, or amlodipine benzoate, has received the FDA's approval. The drug is an oral liquid suspension formulation used to treat hypertension in patients age 6 and older.
FDA OKs Azurity's amlodipine benzoate oral suspension formula
Sign up for BIO SmartBrief
Biotechnology industry news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.